CytexOrtho is developing a first-mover solution for the millions of active patients with early hip disease who are too young for a total hip replacement. The ReNewTM Hip implant is a cutting-edge bioabsorbable medical implant that restores the joint for a prolonged, active lifestyle, instead of replacing it with an artificial implant. Total joint replacements at a young age are on the rise but are far from ideal, requiring significant lifestyle changes to maximize the life of the implant. In spite of these sacrifices, most of these patients still face at least one total joint revision in their lifetime, each of which carries increasing risk of complications and lower patient satisfaction. CytexOrtho’s ReNew Hip is designed to restore the health and activity levels of individuals at disease onset, rather than making them endure chronic disease and pain until the joint deteriorates completely, forcing them to consider a total hip replacement. ReNew Hip was designated a Breakthrough Device by FDA due to its potential to offer new treatment options for these patients who desperately need solutions. This is the long-awaited solution that orthopedic surgeons and patients have eagerly anticipated.